Although care of patients with heart failure (HF) has improved in the past decade, important
disparities in HF outcomes persist based on race/ethnicity. Age-adjusted HF-related …

Among the estimated 6.2 million Americans living with heart failure (HF),≈ 5%/y may
progress to advanced, or stage D, disease. Advanced HF has a high morbidity and mortality …

Importance Racial bias is associated with the allocation of advanced heart failure therapies,
heart transplants, and ventricular assist devices. It is unknown whether gender and racial …

Racial and ethnic minorities have the highest incidence, prevalence, and hospitalization
rates from heart failure. In spite of improved therapies and overall survival, the mortality …

Background Race influences medical decision making, but its impact on advanced heart
failure therapy allocation is unknown. We sought to determine whether patient race …

Importance While left ventricular assist devices (LVADs) increase survival for patients with
advanced heart failure (HF), racial and sex access and outcome inequities remain and are …

Background Racial and ethnic disparities contribute to differences in access and outcomes
for patients undergoing heart transplantation. We evaluated contemporary outcomes for …

Background: Racial disparities in access to advanced therapies for heart failure (HF)
patients are well documented, although the reasons remain uncertain. We sought to …

Abstract Heart failure (HF) affects> 6 million Americans, with variations in incidence,
prevalence, and clinical outcomes by race/ethnicity. Black adults have the highest risk for …

Objectives: This study examined sex-related differences in use and outcomes of continuous-
flow left ventricular assist devices (CF-LVADs) among individuals awaiting heart …